0597-0390-13 |
0597-0390 |
HUMAN PRESCRIPTION DRUG |
Trijardy XR |
empagliflozin, linagliptin, metformin hydrochloride |
TABLET, EXTENDED RELEASE |
ORAL |
20200423 |
N/A |
NDA |
NDA212614 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
25 mg/1; 5 mg/1; 1000 mg/1 |
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-13) |
0597-0390-31 |
0597-0390 |
HUMAN PRESCRIPTION DRUG |
Trijardy XR |
empagliflozin, linagliptin, metformin hydrochloride |
TABLET, EXTENDED RELEASE |
ORAL |
20200423 |
N/A |
NDA |
NDA212614 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
25 mg/1; 5 mg/1; 1000 mg/1 |
1 BOTTLE in 1 CARTON (0597-0390-31) / 7 TABLET, EXTENDED RELEASE in 1 BOTTLE |
0597-0390-71 |
0597-0390 |
HUMAN PRESCRIPTION DRUG |
Trijardy XR |
empagliflozin, linagliptin, metformin hydrochloride |
TABLET, EXTENDED RELEASE |
ORAL |
20200423 |
N/A |
NDA |
NDA212614 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
25 mg/1; 5 mg/1; 1000 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-71) |
0597-0385-77 |
0597-0385 |
HUMAN PRESCRIPTION DRUG |
Trijardy XR |
empagliflozin, linagliptin, metformin hydrochloride |
TABLET, EXTENDED RELEASE |
ORAL |
20200423 |
N/A |
NDA |
NDA212614 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
12.5 mg/1; 2.5 mg/1; 1000 mg/1 |
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-77) |
0597-0385-86 |
0597-0385 |
HUMAN PRESCRIPTION DRUG |
Trijardy XR |
empagliflozin, linagliptin, metformin hydrochloride |
TABLET, EXTENDED RELEASE |
ORAL |
20200423 |
N/A |
NDA |
NDA212614 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
12.5 mg/1; 2.5 mg/1; 1000 mg/1 |
180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86) |
0597-0385-88 |
0597-0385 |
HUMAN PRESCRIPTION DRUG |
Trijardy XR |
empagliflozin, linagliptin, metformin hydrochloride |
TABLET, EXTENDED RELEASE |
ORAL |
20200423 |
N/A |
NDA |
NDA212614 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
12.5 mg/1; 2.5 mg/1; 1000 mg/1 |
1 BOTTLE in 1 CARTON (0597-0385-88) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE |
0597-0380-13 |
0597-0380 |
HUMAN PRESCRIPTION DRUG |
Trijardy XR |
empagliflozin, linagliptin, metformin hydrochloride |
TABLET, EXTENDED RELEASE |
ORAL |
20200423 |
N/A |
NDA |
NDA212614 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
10 mg/1; 5 mg/1; 1000 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-13) |
0597-0380-68 |
0597-0380 |
HUMAN PRESCRIPTION DRUG |
Trijardy XR |
empagliflozin, linagliptin, metformin hydrochloride |
TABLET, EXTENDED RELEASE |
ORAL |
20200423 |
N/A |
NDA |
NDA212614 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
10 mg/1; 5 mg/1; 1000 mg/1 |
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-68) |
0597-0395-82 |
0597-0395 |
HUMAN PRESCRIPTION DRUG |
Trijardy XR |
empagliflozin, linagliptin, metformin hydrochloride |
TABLET, EXTENDED RELEASE |
ORAL |
20200423 |
N/A |
NDA |
NDA212614 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
5 mg/1; 2.5 mg/1; 1000 mg/1 |
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0395-82) |
0597-0395-23 |
0597-0395 |
HUMAN PRESCRIPTION DRUG |
Trijardy XR |
empagliflozin, linagliptin, metformin hydrochloride |
TABLET, EXTENDED RELEASE |
ORAL |
20200423 |
N/A |
NDA |
NDA212614 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
5 mg/1; 2.5 mg/1; 1000 mg/1 |
180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0395-23) |